NOVARNICA
NOVARNICA, licence 80037726: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Anti-Inflammatory, Anti-Inflammatory Double Action, Anti-Inflammatory Joint, Anti-Inflammatory Muscle, Anti-Pain, Arnica Spray
- Licence holder
- JETAFAM INC.
- NPN or DIN-HM
- 80037726
- Status
- Active licence
- Licence date
- 23 November 2012
- Revision date
- 29 December 2023
- Form
- Vaporisateur
- Route of administration
- Topique
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile essentielle de girofle Source : Huile essentielle de girofle | 0.25 Pour cent | Not calculated |
| Arnica montana Source : Arnica Montana - fleur Extraction ratio : 1.0:5.0 Dry plant equivalent : 4.0 g | 20.0 Pour cent | Not calculated |
Non-medicinal ingredients
Poly(sorbate) 20, Huile essentielle de menthe poivrée, Alcool isopropylique, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescentes | minimum: 13.0 Année(s) ; maximum: 18.0 Année(s) | 1.0 Pulvérisateur | minimum: 3.0 Jour(s) ; maximum: 4.0 Jour(s) |
| Adultes | Not specified | 1.0 Pulvérisateur | minimum: 3.0 Jour(s) ; maximum: 4.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Arnica is (traditionally) used in Herbal Medicine to help relieve pain and/or inflammation in muscles and joints (e.g. sprains, bruises, joint pain). Temporarily relieves aches and pains of muscles and joints associated with one or more of the following: simple backache, lumbago, trains and sprains (involving muscles, tendons, and/or ligaments), and arthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80037726
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.